Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vital Farms (VITL) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Vital Farms (VITL) over the last 7 years, with Q3 2025 value amounting to $93.8 million.

  • Vital Farms' Cash & Equivalents fell 3727.45% to $93.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.8 million, marking a year-over-year decrease of 3727.45%. This contributed to the annual value of $150.6 million for FY2024, which is 7896.94% up from last year.
  • Vital Farms' Cash & Equivalents amounted to $93.8 million in Q3 2025, which was down 3727.45% from $108.2 million recorded in Q2 2025.
  • Over the past 5 years, Vital Farms' Cash & Equivalents peaked at $156.3 million during Q1 2025, and registered a low of $12.9 million during Q4 2022.
  • Over the past 5 years, Vital Farms' median Cash & Equivalents value was $47.7 million (recorded in 2023), while the average stood at $70.0 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 7527.59% in 2021, then skyrocketed by 55161.07% in 2023.
  • Vital Farms' Cash & Equivalents (Quarter) stood at $31.0 million in 2021, then plummeted by 58.3% to $12.9 million in 2022, then soared by 551.61% to $84.1 million in 2023, then surged by 78.97% to $150.6 million in 2024, then tumbled by 37.72% to $93.8 million in 2025.
  • Its Cash & Equivalents was $93.8 million in Q3 2025, compared to $108.2 million in Q2 2025 and $156.3 million in Q1 2025.